Speakers

Jan Terje Andersen, Ph.D.

Professor, University of Oslo and Group Leader

Oslo University Hospital

Stephen Beers, PhD

Professor of Immunology and Immunotherapy

University of Southampton

Kerry Chester, PhD

Professor of Molecular Medicine

UCL Cancer Institute

Rony Dahan, PhD

Principal Investigator

Weizmann Institute of Science

Charlotte Deane, PhD

Professor of Structural Bioinformatics

University of Oxford

James Ernst, Ph.D.

Vice President, Head of Development Sciences

Xencor

Dr. Jane Grogan, PhD

Executive Vice President & Head of Research

Biogen

Katherine Harris, PhD

Chief Development Officer

Rondo Therapeutics

Albert Heck, PhD

Professor of Chemistry and Pharmaceutical Sciences

Utrecht University

Rene Hoet, Ph.D.

Chief Innovation Officer

FairJourney Biologics

Dr. Andreea Ioan-Facsinay, PhD

Director

Genmab

Christian Klein, PhD

CXO in Residence & Drug Hunter

Curie.Bio

Jeanette Leusen, PhD

Associate Professor, Head Immunotherapy Group

University Medical Center Utrecht

Dr. Kathryn (Kate) Monroe, PhD

Director and Principal Scientist

Denali Therapeutics

Jane Osbourn, PhD

CEO

Alchemab Therapeutics

Anna Park, PhD

Distinguished Scientist, Protein Engineering Group Head, LMR US

Sanofi

Mario Perro, PhD

Head of Biologics Research & Site Head, SVP

Ichnos Glenmark Innovation

Dr. Johannes Preiner, PhD

Research Group Leader

University of Applied Sciences Upper Austria

Sai Reddy, PhD

Associate Professor of Systems and Synthetic Immunology

ETH Zurich

Janine Schuurman, Ph.D.

Biotech Consultant

Lust for Life Science

Karen Silence, PhD

Head Preclinical Product Development

Argenx

Jonathan Sockolosky, PhD

Senior Director, CSO Partner Team

Curie.Bio

Anette Sommer, PhD

Head of Biochemistry

Synaffix BV

Dr. Dale Starkie, PhD

Director

DJS Antibodies

Sally Ward, PhD

Professor and Director

University of Southampton